Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Operating Income
Molecular Data Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Operating Income
¥-332m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Operating Income
¥124.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
18%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Operating Income
¥58.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Operating Income
¥35.6m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Operating Income
¥10.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Operating Income
¥28.9B
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Molecular Data Inc's Operating Income?
Operating Income
-332m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Operating Income amounts to -332m CNY.
What is Molecular Data Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-55%
Over the last year, the Operating Income growth was -73%. The average annual Operating Income growth rates for Molecular Data Inc have been -55% over the past three years .